Edwards SAPIEN XT Transcatheter Heart Valve

Optimal hemodynamic performance

Cobalt chromium frame with high radial strength for uniform leaflet coaptation
In real-world practice (n=50)1:
  • 96% circularity was maintained
  • A median 2% difference was detected
    between long and short diameters

Physiologically optimized

Frame height is designed to
respect the surrounding cardiac
anatomy and minimize the risk of:
  • Atrioventricular block
  • Disruption of mitral valve function
  • Interference with coronary ostia

Proven long-term tissue durability2

Clinically proven durability
Edwards bovine pericardial tissue
valves are the gold standard in
surgical valve replacement
Maximized leaflet durability
Leaflet design and matching enhance
stress distribution
Sustained valve performance
The Carpentier-Edwards ThermaFix
process is intended to minimize the risk of
calcification*

Expanded treatment options

The SAPIEN XT valve treats an annulus size range of 18 mm to 27 mm

All Edwards SAPIEN XT valve sizes are available for transfemoral, transapical and transaortic delivery



* No clinical data are available which evaluate the long-term impact of the Edwards Lifesciences tissue process in patients.

Reference:
1. Willson A. Late structural integrity of balloon expandable stents used for transcatheter aortic valve replacement: assessment by multi-detector computerized tomography. J Am Coll Cardiol Intv 2012;5:525–32
abstract presented at: 2011 Transcatheter Cardiovascular Therapeutics; November 8, 2011; San Francisco, CA. Abstract TCT-121.
2. Rahimtoola SH. Choice of Prosthetic Heart Valve in Adults. J. Am Coll Cardiol 2010;55:2413-26
For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse event.

Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.